Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Clovis Oncology Inc. sell nvestor

Clovis Oncology Inc.
Start price
€5.60
09.11.19 / 50%
Target price
€0.000
23.11.19
Performance (%)
42.97%
End price
€8.00
23.11.19
Summary
This prediction ended on 23.11.19 with a price of €8.00. The SELL prediction by nvestor for Clovis Oncology Inc. was trending in the completely wrong direction and closed with a performance of 42.97%. nvestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Clovis Oncology Inc. - - - -
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to nvestor what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Some uniques
Growths faster than the competition
Fair valuation
High dividend yield expected
Standard Investments for future growth
Valuable balance sheet
positive Cash Flow expected
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Innovative
Good culture
Sustainability is important
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons

Comments by nvestor for this prediction

In the thread Clovis Oncology Inc. diskutieren

Sell mit Kursziel 0,0

nvestor 
0
Report Share
09.11.19 Sell 42.97%
Prediction Sell
Perf. (%) 42.97%
Target price 0.000
Change
Ends at 23.11.19

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.

nvestor 
0
Report Share
23.11.19

Stopped prediction by nvestor for Clovis Oncology Inc.

sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€6.14
20.03.21
€3.00
20.03.22
-1.27%
03.04.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
20.03.21 50%